{"pageContent": "Purpose: In recent years there has been increased interest in adjuvant therapy for prostate cancer. This trend has engendered a tendency toward overlooking the issue of therapy to the primary tumor in advanced disease. We reviewed the effect of treating the principal disease bulk on overall treatment outcome in patients with advanced and metastatic cancer. Specifically we evaluated the role of surgical tumor cytoreduction.", "metaData": {"source": "Current status of radical prostatectomy for high-risk prostate cancer\nhttps://pubmed.ncbi.nlm.nih.gov/25324944/"}}